Homology Medicines, Inc. Forecast, price target & analysts
$2.32
2.93%
yesterday
Nasdaq,
Nov 06, 10:00 pm CET
Homology Medicines, Inc. Target price 2025 - Analyst rating & recommendation
Powered by
Homology Medicines, Inc. Classifications & Recommendation:
Buy
67%
Hold
33%
Homology Medicines, Inc. Price Target
| Target Price | $8.16 |
| Price | $2.32 |
| Potential |
251.72%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target Homology Medicines, Inc. 2026 .
The average Homology Medicines, Inc. target price is $8.16.
This is
251.72%
register free of charge
$21.00
805.17%
register free of charge
$4.04
74.14%
register free of charge
|
|
| A rating was issued by 9 analysts: 6 Analysts recommend Homology Medicines, Inc. to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Homology Medicines, Inc. stock has an average upside potential 2026 of
251.72%
register free of charge
|
Current Homology Medicines, Inc. Upgrades & Downgrades
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Wells Fargo |
Locked
➜
Locked
|
Locked | Mar 12 2025 |
| BMO Capital |
Locked
➜
Locked
|
Locked | Feb 11 2025 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Feb 11 2025 |
| BMO Capital |
Locked
➜
Locked
|
Locked | Dec 12 2024 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Dec 12 2024 |
| Leerink Partners |
Locked
➜
Locked
|
Locked | Dec 11 2024 |
| Oppenheimer |
Locked
➜
Locked
|
Locked | Dec 11 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Mar 12 2025 |
|
Locked
BMO Capital:
Locked
➜
Locked
|
Feb 11 2025 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Feb 11 2025 |
|
Locked
BMO Capital:
Locked
➜
Locked
|
Dec 12 2024 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Dec 12 2024 |
|
Locked
Leerink Partners:
Locked
➜
Locked
|
Dec 11 2024 |
|
Locked
Oppenheimer:
Locked
➜
Locked
|
Dec 11 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
